天堂网亚洲,天天操天天搞,91视频高清,菠萝蜜视频在线观看入口,美女视频性感美女视频,95丝袜美女视频国产,超高清美女视频图片

β-D-Glucopyranosiduronic acid, (2R,5S,13aR)-2,3,4,5,7,9,13,13a-octahydro-7,9-dioxo-10-[[[(2,4,6-trifluorophenyl)methyl]amino]carbonyl]-2,5-methanopyrido[1',2':4,5]pyrazino[2,1-b][1,3]oxazepin-8-yl

β-D-Glucopyranosiduronic acid, (2R,5S,13aR)-2,3,4,5,7,9,13,13a-octahydro-7,9-dioxo-10-[[[(2,4,6-trifluorophenyl)methyl]amino]carbonyl]-2,5-methanopyrido[1',2':4,5]pyrazino[2,1-b][1,3]oxazepin-8-yl Struktur
2365156-60-9
CAS-Nr.
2365156-60-9
Englisch Name:
β-D-Glucopyranosiduronic acid, (2R,5S,13aR)-2,3,4,5,7,9,13,13a-octahydro-7,9-dioxo-10-[[[(2,4,6-trifluorophenyl)methyl]amino]carbonyl]-2,5-methanopyrido[1',2':4,5]pyrazino[2,1-b][1,3]oxazepin-8-yl
Synonyma:
Bikagwe metabolite M15;Bictegravir Impurity 9;Ambrisentan Impurity 1-d3（Ambrisentan Racemate-d3）;Bictegravir Metabolite M15Q: What is Bictegravir Metabolite M15 Q: What is the CAS Number of Bictegravir Metabolite M15;β-D-Glucopyranosiduronic acid, (2R,5S,13aR)-2,3,4,5,7,9,13,13a-octahydro-7,9-dioxo-10-[[[(2,4,6-trifluorophenyl)methyl]amino]carbonyl]-2,5-methanopyrido[1',2':4,5]pyrazino[2,1-b][1,3]oxazepin-8-yl;(2S,3S,4S,5R,6S)-6-(((2R,5S,13aR)-7,9-Dioxo-10-((2,4,6-trifluorobenzyl)carbamoyl)-2,3,4,5,7,9,13,13a-octahydro-2,5-methanopyrido[1'',2'':4,5]pyrazino[2,1-b][1,3]oxazepin-8-yl)oxy)-3,4,5-trihydroxytetrahydro-2H-pyran-2-carboxylic acid
CBNumber:
CB99781284
Summenformel:
C27H26F3N3O11
Molgewicht:
625.51
MOL-Datei:
2365156-60-9.mol

β-D-Glucopyranosiduronic acid, (2R,5S,13aR)-2,3,4,5,7,9,13,13a-octahydro-7,9-dioxo-10-[[[(2,4,6-trifluorophenyl)methyl]amino]carbonyl]-2,5-methanopyrido[1',2':4,5]pyrazino[2,1-b][1,3]oxazepin-8-yl Eigenschaften

Siedepunkt:
945.8±65.0 °C(Predicted)
Dichte
1.75±0.1 g/cm3(Predicted)
pka
2.76±0.70(Predicted)

Sicherheit

β-D-Glucopyranosiduronic acid, (2R,5S,13aR)-2,3,4,5,7,9,13,13a-octahydro-7,9-dioxo-10-[[[(2,4,6-trifluorophenyl)methyl]amino]carbonyl]-2,5-methanopyrido[1',2':4,5]pyrazino[2,1-b][1,3]oxazepin-8-yl Chemische Eigenschaften,Einsatz,Produktion Methoden

β-D-Glucopyranosiduronic acid, (2R,5S,13aR)-2,3,4,5,7,9,13,13a-octahydro-7,9-dioxo-10-[[[(2,4,6-trifluorophenyl)methyl]amino]carbonyl]-2,5-methanopyrido[1',2':4,5]pyrazino[2,1-b][1,3]oxazepin-8-yl Upstream-Materialien And Downstream Produkte

Upstream-Materialien

Downstream Produkte

β-D-Glucopyranosiduronic acid, (2R,5S,13aR)-2,3,4,5,7,9,13,13a-octahydro-7,9-dioxo-10-[[[(2,4,6-trifluorophenyl)methyl]amino]carbonyl]-2,5-methanopyrido[1',2':4,5]pyrazino[2,1-b][1,3]oxazepin-8-yl Anbieter Lieferant Produzent Hersteller Vertrieb H?ndler.

Global( 5)Lieferanten
Firmenname Telefon E-Mail Land Produktkatalog Edge Rate
Guangzhou Jiuzhi Pharmaceutical Technology Co., Ltd. 020-89854820
sales@jzpharma.cn China 1130 58
Shenzhen Roark Pharma-Tec Co., Ltd. 13128912434
 2880126944@qq.com China 2577 58
Hubei Moco Chemical Co., Ltd. 18627753421 18627756402
 3001009495@qq.com China 19063 58
  • β-D-Glucopyranosiduronic acid, (2R,5S,13aR)-2,3,4,5,7,9,13,13a-octahydro-7,9-dioxo-10-[[[(2,4,6-trifluorophenyl)methyl]amino]carbonyl]-2,5-methanopyrido[1',2':4,5]pyrazino[2,1-b][1,3]oxazepin-8-yl
  • Bictegravir Metabolite M15Q: What is Bictegravir Metabolite M15 Q: What is the CAS Number of Bictegravir Metabolite M15
  • Bictegravir Impurity 9
  • (2S,3S,4S,5R,6S)-6-(((2R,5S,13aR)-7,9-Dioxo-10-((2,4,6-trifluorobenzyl)carbamoyl)-2,3,4,5,7,9,13,13a-octahydro-2,5-methanopyrido[1'',2'':4,5]pyrazino[2,1-b][1,3]oxazepin-8-yl)oxy)-3,4,5-trihydroxytetrahydro-2H-pyran-2-carboxylic acid
  • Bikagwe metabolite M15
  • Ambrisentan Impurity 1-d3（Ambrisentan Racemate-d3）
  • 2365156-60-9
  • C27H26F3N3O11
Copyright 2019 ? ChemicalBook. All rights reserved